Anthony D. Ho

Research interests

Publications

• Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

  Leukemia · 2017 · https://doi.org/10.1038/leu.2017.253

• Human haematopoietic stem cell lineage commitment is a continuous process

  Nature Cell Biology · 2017 · https://doi.org/10.1038/ncb3493

• BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation

  Nature · 2017 · https://doi.org/10.1038/nature24294

• Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

  Cancer Cell · 2017 · https://doi.org/10.1016/j.ccell.2017.02.002

• Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia

  Blood · 2016 · https://doi.org/10.1182/blood-2016-01-689422

• A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis

  Blood · 2014 · https://doi.org/10.1182/blood-2014-04-570010

• Longitudinal Left Ventricular Function for Prediction of Survival in Systemic Light-Chain Amyloidosis

  Journal of the American College of Cardiology · 2012 · https://doi.org/10.1016/j.jacc.2012.04.043

• Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

  The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60689-8

• Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

  Blood · 2011 · https://doi.org/10.1182/blood-2011-09-379164

• Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

  Blood · 2011 · https://doi.org/10.1182/blood-2011-08-373902

• Two-stage Exchange Arthroplasty for Infected Total Knee Arthroplasty: Predictors of Failure

  Clinical Orthopaedics and Related Research · 2011 · https://doi.org/10.1007/s11999-011-2030-8

• Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2009.25.5356

• Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

  Journal of Clinical Oncology · 2010 · https://doi.org/10.1200/jco.2010.29.8018

• Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

  Blood · 2010 · https://doi.org/10.1182/blood-2010-02-270785

• Aging and Replicative Senescence Have Related Effects on Human Stem and Progenitor Cells

  PLoS ONE · 2009 · https://doi.org/10.1371/journal.pone.0005846

• DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cells

  Aging Cell · 2009 · https://doi.org/10.1111/j.1474-9726.2009.00535.x

• Poor Mobilization of Hematopoietic Stem Cells—Definitions, Incidence, Risk Factors, and Impact on Outcome of Autologous Transplantation

  Transplantation and Cellular Therapy · 2009 · https://doi.org/10.1016/j.bbmt.2009.11.012

• Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

  The Lancet Oncology · 2008 · https://doi.org/10.1016/s1470-2045(08)70078-0

• Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

  The Lancet Oncology · 2008 · https://doi.org/10.1016/s1470-2045(08)70002-0

• Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process

  PLoS ONE · 2008 · https://doi.org/10.1371/journal.pone.0002213

• VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma

  British Journal of Cancer · 2008 · https://doi.org/10.1038/sj.bjc.6604508

• Modeling of Asymmetric Cell Division in Hematopoietic Stem Cells—Regulation of Self-Renewal Is Essential for Efficient Repopulation

  Stem Cells and Development · 2008 · https://doi.org/10.1089/scd.2008.0143

• Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

  International Journal of Radiation Oncology*Biology*Physics · 2005 · https://doi.org/10.1016/j.ijrobp.2005.07.002

• Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood

  Experimental Hematology · 2005 · https://doi.org/10.1016/j.exphem.2005.07.003

• Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

  International Journal of Radiation Oncology*Biology*Physics · 2004 · https://doi.org/10.1016/j.ijrobp.2003.11.004

• Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group

  Journal of Clinical Oncology · 2003 · https://doi.org/10.1200/jco.2003.12.011

• Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

  Journal of Clinical Oncology · 1998 · https://doi.org/10.1200/jco.1998.16.8.2825

Current projects

No projects listed.